Bohai Pharmaceutical (BOPH)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 06/30
(Values in U.S. thousands)
| 09-2014 | 06-2014 | 03-2014 | 12-2013 | 09-2013 | |
| Sales | 54,743 | 45,802 | 39,722 | 38,673 | 50,889 |
| Cost of Goods | 15,534 | 11,497 | 10,125 | 9,046 | 11,708 |
| Gross Profit | 39,209 | 34,305 | 29,597 | 29,627 | 39,181 |
| Operating Expenses | 26,731 | 28,293 | 23,951 | 20,769 | 28,662 |
| Operating Income | 13,012 | 6,509 | 5,771 | 8,905 | 11,227 |
| Interest Expense | 437 | 731 | 337 | 857 | 362 |
| Other Income | 57 | 1,384 | 3 | 67 | -23 |
| Pre-tax Income | 12,631 | 7,162 | 5,437 | 8,115 | 10,842 |
| Income Tax | 3,287 | 3,297 | 1,509 | 2,106 | 2,754 |
| Net Income Continuous | 9,344 | 3,864 | 3,928 | 6,009 | 8,088 |
| Net Income | $9,344 | $3,864 | $3,928 | $6,009 | $8,088 |
| EPS Basic Total Ops | 0.50 | 0.21 | 0.22 | 0.34 | 0.45 |
| EPS Basic Continuous Ops | 0.50 | 0.21 | 0.22 | 0.34 | 0.45 |
| EPS Diluted Total Ops | 0.47 | 0.17 | 0.19 | 0.28 | 0.38 |
| EPS Diluted Continuous Ops | 0.46 | 0.18 | 0.18 | 0.27 | 0.37 |
| EBITDA(a) | $14,676 | $7,178 | $7,402 | $10,522 | $12,833 |